Suppr超能文献

肝非实质细胞:酒精性肝病的主要调节因子?

Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

作者信息

Seo Wonhyo, Jeong Won-Il

机构信息

Wonhyo Seo, Won-Il Jeong, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 305-338, South Korea.

出版信息

World J Gastroenterol. 2016 Jan 28;22(4):1348-56. doi: 10.3748/wjg.v22.i4.1348.

Abstract

Chronic alcohol consumption is one of the most common causes of the progression of alcoholic liver disease (ALD). In the past, alcohol-mediated hepatocyte injury was assumed to be a significantly major cause of ALD. However, a huge number of recent and brilliant studies have demonstrated that hepatic non-parenchymal cells including Kupffer cells, hepatic stellate cells, liver sinusoidal endothelial cells and diverse types of lymphocytes play crucial roles in the pathogenesis of ALD by producing inflammatory mediators such as cytokines, oxidative stress, microRNA, and lipid-originated metabolites (retinoic acid and endocannabinoids) or by directly interacting with parenchymal cells (hepatocytes). Therefore, understanding the comprehensive roles of hepatic non-parenchymal cells during the development of ALD will provide new integrative directions for the treatment of ALD. This review will address the roles of non-parenchymal cells in alcoholic steatosis, inflammation, and liver fibrosis and might help us to discover possible therapeutic targets and treatments involving modulating the non-parenchymal cells in ALD.

摘要

长期饮酒是酒精性肝病(ALD)进展的最常见原因之一。过去,酒精介导的肝细胞损伤被认为是ALD的一个重要主要原因。然而,最近大量出色的研究表明,包括库普弗细胞、肝星状细胞、肝窦内皮细胞和多种淋巴细胞在内的肝脏非实质细胞,通过产生细胞因子、氧化应激、微小RNA和脂质源性代谢产物(视黄酸和内源性大麻素)等炎症介质,或通过与实质细胞(肝细胞)直接相互作用,在ALD的发病机制中发挥关键作用。因此,了解肝脏非实质细胞在ALD发生发展过程中的综合作用,将为ALD的治疗提供新的综合方向。本综述将探讨非实质细胞在酒精性脂肪变性、炎症和肝纤维化中的作用,并可能有助于我们发现涉及调节ALD中非实质细胞的潜在治疗靶点和治疗方法。

相似文献

1
Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
World J Gastroenterol. 2016 Jan 28;22(4):1348-56. doi: 10.3748/wjg.v22.i4.1348.
2
Immunology in alcoholic liver disease.
Clin Liver Dis. 2012 Nov;16(4):687-98. doi: 10.1016/j.cld.2012.08.003.
3
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease.
Am J Pathol. 2020 Nov;190(11):2185-2193. doi: 10.1016/j.ajpath.2020.08.014. Epub 2020 Sep 11.
4
Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.
J Dig Dis. 2011 Feb;12(1):3-9. doi: 10.1111/j.1751-2980.2010.00468.x.
5
Fibrogenesis in alcoholic liver disease.
World J Gastroenterol. 2014 Jul 7;20(25):8048-54. doi: 10.3748/wjg.v20.i25.8048.
6
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.
Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G30-41. doi: 10.1152/ajpgi.00031.2015. Epub 2015 Apr 30.
7
The functional role of microRNAs in alcoholic liver injury.
J Cell Mol Med. 2014 Feb;18(2):197-207. doi: 10.1111/jcmm.12223. Epub 2014 Jan 8.
9
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
World J Gastroenterol. 2014 Dec 21;20(47):17756-72. doi: 10.3748/wjg.v20.i47.17756.
10
Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review.
Int Immunopharmacol. 2024 Nov 15;141:112938. doi: 10.1016/j.intimp.2024.112938. Epub 2024 Aug 18.

引用本文的文献

1
Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives.
ADMET DMPK. 2025 Aug 4;13(4):2874. doi: 10.5599/admet.2874. eCollection 2025.
2
Current hPSC-derived liver organoids for toxicity testing: Cytochrome P450 enzymes and drug metabolism.
Toxicol Res. 2025 Jan 3;41(2):105-121. doi: 10.1007/s43188-024-00275-8. eCollection 2025 Mar.
3
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways.
Liver Res. 2022 Oct 3;7(1):1-8. doi: 10.1016/j.livres.2022.09.004. eCollection 2023 Mar.
5
The impact of matrix stiffness on hepatic cell function, liver fibrosis, and hepatocellular carcinoma-Based on quantitative data.
Biophys Rev (Melville). 2024 Jun 3;5(2):021306. doi: 10.1063/5.0197875. eCollection 2024 Jun.
6
Treatment with β-Adrenoceptor Agonist Isoproterenol Reduces Non-parenchymal Cell Responses in LPS/D-GalN-Induced Liver Injury.
Inflammation. 2024 Apr;47(2):733-752. doi: 10.1007/s10753-023-01941-z. Epub 2023 Dec 21.
7
Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles.
Front Immunol. 2023 Sep 29;14:1205821. doi: 10.3389/fimmu.2023.1205821. eCollection 2023.
8
Oxidative Stress in Liver Pathophysiology and Disease.
Antioxidants (Basel). 2023 Aug 22;12(9):1653. doi: 10.3390/antiox12091653.

本文引用的文献

1
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.
J Hepatol. 2015 Jun;62(6):1311-8. doi: 10.1016/j.jhep.2014.12.027. Epub 2015 Jan 10.
2
Energy metabolism in the liver.
Compr Physiol. 2014 Jan;4(1):177-97. doi: 10.1002/cphy.c130024.
5
Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:99-104. doi: 10.1111/jgh.12017.
7
Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.
J Clin Invest. 2013 Feb;123(2):887-902. doi: 10.1172/JCI65647. Epub 2013 Jan 25.
9
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
J Clin Invest. 2012 Oct;122(10):3476-89. doi: 10.1172/JCI60777. Epub 2012 Sep 4.
10
Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Gastroenterology. 2012 Sep;143(3):765-776.e3. doi: 10.1053/j.gastro.2012.05.049. Epub 2012 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验